IL4R and B-cell chronic lymphocytic leukemia: Furthermore, activation of IL-4R and vascular endothelial growth factor receptor (VEGF-R) on CLL cells leads to activation of STAT1/STAT3 and increased survival of CLL cells [35], [36].